Welcome to IJSDR UGC CARE norms ugc approved journal norms IJRTI Research Journal | ISSN : 2455-2631
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.15 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
In the last three decades, more than 20 therapeutic Monoclonal Antibodies targeting a range of antigens (Working through a variety of mechanisms) have been approved for treatment of serious diseases. The first to be approved were murine antibodies, followed by humanized molecules with superior efficacy, safety and tolerance. Most of Monoclonal Antibodies have been produced by different methods using the various animals and hybridoma technology. In addition to this, the in Vivo and in Vitro manufacture of Monoclonal Antibodies is carried out to ensure the finished product of pharmaceutical quality. These Monoclonal Antibodies can be used to treat the various types of diseases including the cancer.
Keywords:
Monoclonal, Superior Epicacy, Cancer.
Cite Article:
"Monoclonal Antibodies : Structure and Applications : A Review", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.7, Issue 12, page no.738 - 743, December-2022, Available :http://www.ijsdr.org/papers/IJSDR2212115.pdf
Downloads:
000201531
Publication Details:
Published Paper ID: IJSDR2212115
Registration ID:203111
Published In: Volume 7 Issue 12, December-2022
DOI (Digital Object Identifier):
Page No: 738 - 743
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn